Shelley Shapiro

Title(s)HS Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells. EBioMedicine. 2024 Feb; 100:104900. Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, Saggar R, Mirocha J, Karpov OA, Van Eyk JE, Marbán E. PMID: 38092579; PMCID: PMC10879003.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    2. BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension. Pulm Circ. 2022 Apr; 12(2):e12063. Spikes LA, Bajwa AA, Burger CD, Desai SV, Eggert MS, El-Kersh KA, Fisher MR, Johri S, Joly JM, Mehta J, Palevsky HI, Ramani GV, Restrepo-Jaramillo R, Sahay S, Shah TG, Deng C, Miceli M, Smith P, Shapiro SM. PMID: 35514770; PMCID: PMC9063953.
      View in: PubMed   Mentions: 5  
    3. Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial. Pulm Circ. 2022 Jan; 12(1):e12043. Maron BA, Choudhary G, Goldstein RL, Garshick E, Jankowich M, Tucker TJS, LaCerda KA, Hattler B, Dempsey EC, Sadikot RT, Shapiro S, Rounds SI, Goldstein RH. PMID: 35506072; PMCID: PMC9053004.
      View in: PubMed   Mentions: 3  
    4. Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial. Am J Respir Crit Care Med. 2022 01 15; 205(2):198-207. Nathan SD, Tapson VF, Elwing J, Rischard F, Mehta J, Shapiro S, Shen E, Deng C, Smith P, Waxman A. PMID: 34767495; PMCID: PMC8787243.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    5. Implantable system for treprostinil: a real-world patient experience study. Pulm Circ. 2020 Apr-Jun; 10(2):2045894020907881. Shapiro S, Bourge RC, Pozella P, Harris DF, Borg EH, Nelsen AC. PMID: 32363029; PMCID: PMC7177997.
      View in: PubMed   Mentions: 3  
    6. Long-term results of the DelIVery for Pulmonary Arterial Hypertension trial. Pulm Circ. 2019 Oct-Dec; 9(4):2045894019878615. Gomberg-Maitland M, Bourge RC, Shapiro SM, Tarver JH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Torres F, Bag R, Murphy JA, Lautenbach AA, Morris M, Peterson L, Waxman AB. PMID: 31723407; PMCID: PMC6831973.
      View in: PubMed   Mentions: 6  
    7. Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1). Respir Med. 2017 05; 126:84-92. Shapiro S, Torres F, Feldman J, Keogh A, Allard M, Blair C, Gillies H, Tislow J, Oudiz RJ. PMID: 28427554.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    8. Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial. Chest. 2016 Jul; 150(1):27-34. Bourge RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, Tarver JH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Torres F, Cerkvenik J, Morris M, Thalin M, Peterson L, Rubin LJ. PMID: 27396777.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    9. Response. Chest. 2014 Feb; 145(2):414-5. Bersohn MM, Shapiro S. PMID: 24493520.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis. Thorax. 2014 Feb; 69(2):123-9. Saggar R, Khanna D, Vaidya A, Derhovanessian A, Maranian P, Duffy E, Belperio JA, Weigt SS, Dua S, Shapiro SS, Goldin JG, Abtin F, Lynch JP, Ross DJ, Forfia PR, Saggar R. PMID: 24431095.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    11. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial. Pulm Circ. 2013 Dec; 3(4):889-97. Maron BA, Goldstein RH, Rounds SI, Shapiro S, Jankowich M, Garshick E, Moy ML, Gagnon D, Choudhary G. PMID: 25006405; PMCID: PMC4070834.
      View in: PubMed   Mentions: 5  
    12. Safety, tolerability, and efficacy of overnight switching from sildenafil to tadalafil in patients with pulmonary arterial hypertension. Cardiovasc Ther. 2013 Oct; 31(5):274-9. Shapiro S, Traiger G, Hill W, Zhang L, Doran AK. PMID: 23841794.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    13. Systemic BP and heart rate as prognostic indicators in pulmonary arterial hypertension. Chest. 2013 Sep; 144(3):959-965. Bersohn MM, Turner MP, Traiger GL, Frost AE, Shapiro S. PMID: 23598723.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Ther. 2013 Feb; 31(1):38-44. Bourge RC, Tapson VF, Safdar Z, Benza RL, Channick RN, Rosenzweig EB, Shapiro S, White RJ, McSwain CS, Gotzkowsky SK, Nelsen AC, Rubin LJ. PMID: 22970909; PMCID: PMC3561685.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    15. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. Chest. 2012 Dec; 142(6):1383-1390. Tapson VF, Torres F, Kermeen F, Keogh AM, Allen RP, Frantz RP, Badesch DB, Frost AE, Shapiro SM, Laliberte K, Sigman J, Arneson C, Galiè N. PMID: 22628490.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    16. Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit. J Crit Care. 2012 Dec; 27(6):739.e7-13. Huynh TN, Weigt SS, Sugar CA, Shapiro S, Kleerup EC. PMID: 23089677.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    17. Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan. Am J Cardiol. 2012 Nov 01; 110(9):1373-7. Shapiro S, Pollock DM, Gillies H, Henig N, Allard M, Blair C, Anglen C, Kohan DE. PMID: 22858181; PMCID: PMC4167616.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    18. Catheter ablation of typical atrial flutter in severe pulmonary hypertension. J Cardiovasc Electrophysiol. 2012 Nov; 23(11):1185-90. Bradfield J, Shapiro S, Finch W, Tung R, Boyle NG, Buch E, Mathuria N, Mandapati R, Shivkumar K, Bersohn M. PMID: 22734591.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    19. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Chest. 2012 Feb; 141(2):363-373. Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P, Barst RJ. PMID: 21757572.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    20. ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension. Cardiovasc Ther. 2012 Apr; 30(2):93-9. Badesch DB, Feldman J, Keogh A, Mathier MA, Oudiz RJ, Shapiro S, Farber HW, McGoon M, Frost A, Allard M, Despain D, Dufton C, Rubin LJ, ARIES-3 Study Group. PMID: 21884013.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    21. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum. 2010 Dec; 62(12):3741-50. Saggar R, Khanna D, Furst DE, Shapiro S, Maranian P, Belperio JA, Chauhan N, Clements P, Gorn A, Weigt SS, Ross D, Lynch JP, Saggar R. PMID: 20722025; PMCID: PMC7065301.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    22. Percutaneous intervention of left main coronary artery compression by pulmonary artery aneurysm. Catheter Cardiovasc Interv. 2010 Sep 01; 76(3):352-6. Vaseghi M, Lee MS, Currier J, Tobis J, Shapiro S, Aboulhosn J. PMID: 20552652.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med. 2010 Nov 01; 182(9):1171-7. Ghofrani HA, Morrell NW, Hoeper MM, Olschewski H, Peacock AJ, Barst RJ, Shapiro S, Golpon H, Toshner M, Grimminger F, Pascoe S. PMID: 20581169; PMCID: PMC3001259.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCTClinical Trials
    24. Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation. J Heart Lung Transplant. 2009 Sep; 28(9):964-7. Saggar R, Shapiro SS, Ross DJ, Fishbein MC, Zisman DA, Lynch JP, Weigt SS, Ardehali A, Belperio JA, Saggar R. PMID: 19716051.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009 Jun 09; 119(22):2894-903. Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, Shapiro S, White RJ, Chan M, Beardsworth A, Frumkin L, Barst RJ, Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group. PMID: 19470885.
      View in: PubMed   Mentions: 335     Fields:    Translation:Humans
    26. Transition from IV to subcutaneous prostacyclin: premature withdrawal? Chest. 2007 Sep; 132(3):741-3. Shapiro S, Hill NS. PMID: 17873184.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis. 2007 Nov; 66(11):1467-72. Girgis RE, Frost AE, Hill NS, Horn EM, Langleben D, McLaughlin VV, Oudiz RJ, Robbins IM, Seibold JR, Shapiro S, Tapson VF, Barst RJ. PMID: 17472992; PMCID: PMC2111639.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    28. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol. 2006 May 16; 47(10):2049-56. Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, Naeije R, Galie N, STRIDE-2 Study Group. PMID: 16697324.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    29. Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2005 Aug 02; 46(3):529-35. Galié N, Badesch D, Oudiz R, Simonneau G, McGoon MD, Keogh AM, Frost AE, Zwicke D, Naeije R, Shapiro S, Olschewski H, Rubin LJ. PMID: 16053970.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansCTClinical Trials
    30. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004 Feb 15; 169(4):441-7. Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, McLaughlin V, Hill N, Tapson VF, Robbins IM, Zwicke D, Duncan B, Dixon RA, Frumkin LR, STRIDE-1 Study Group. PMID: 14630619.
      View in: PubMed   Mentions: 144     Fields:    Translation:HumansCTClinical Trials
    31. Management of pulmonary hypertension resulting from interstitial lung disease. Curr Opin Pulm Med. 2003 Sep; 9(5):426-30. Shapiro S. PMID: 12904715.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003 Jun 18; 41(12):2119-25. Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R, Beraprost Study Group. PMID: 12821234.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansCTClinical Trials
    33. [Clinical study on long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol infusion]. Zhonghua Nei Ke Za Zhi. 2003 Feb; 42(2):106-9. Cao TS, Yuan LJ, Duan YY, Wang ZJ, Zhuang L, Shapiro SM, Brundage BH. PMID: 12783707.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002 Feb 01; 165(3):341-4. Hoeper MM, Galié N, Murali S, Olschewski H, Rubenfire M, Robbins IM, Farber HW, McLaughlin V, Shapiro S, Pepke-Zaba J, Winkler J, Ewert R, Opitz C, Westerkamp V, Vachiéry JL, Torbicki A, Behr J, Barst RJ. PMID: 11818318.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Shelley's Networks
    Concepts (154)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California